Well-controlled disease activity with drug treatment will not improve the frailty status of RA patients to robust state: A multicenter observational study (T-FLAG).
Int J Rheum Dis
; 27(1): e14946, 2024 Jan.
Article
em En
| MEDLINE
| ID: mdl-37975650
ABSTRACT
OBJECTIVES:
To investigate a plateau in treatment enhancement for improving the frailty status of rheumatoid arthritis (RA) patients.METHODS:
A total of 345 RA patients who were not robust in 2021 were assigned to the improved ("robust 2022," n = 51) and non-improved ("pre-frailty/frailty 2022," n = 294) groups. Factors associated with "robust 2022" were examined by logistic regression analysis. Patients were assigned to the stable (Follow-up mean DAS28-ESR in 2020 and 2021 < 3.2, n = 225) and unstable (≥3.2, n = 120) groups, which were further divided into the non-improved (stable n = 180, unstable n = 114) and improved (stable n = 45, unstable n = 6) groups. Factors influencing Japanese Cardiovascular Health Study (J-CHS) score were examined by multiple regression analysis. Changes over 2 years were compared between the non-improved and improved groups of the stable group.RESULTS:
The associated factor of "robust 2022" was the follow-up meanDAS28-ESR in 2020 and 2021 < 3.2 (i.e., stable state) (OR 4.01). Follow-up mean DAS28-ESR in 2020 and 2021 was associated with J-CHS score (T = 2.536, p = .013) only in the unstable group. In the stable group, HAQ-DI was lower (2020 0.32 vs. 0.16; 2021 0.32 vs. 0.17; 2022 0.32 vs. 0.21), and the proportion of J-CHS Q4 (weakness) was lower (2020 48.4 vs. 17.8%; 2021 55.0 vs. 29.2%; 2022 50.4 vs. 0%), in the improved group than in the non-improved group, whereas both groups maintained clinical and functional remission over 2 years.CONCLUSIONS:
Drug treatment to maintain well-controlled disease activity alone is insufficient for improving patients' frailty status after achieving treat-to-target goals, suggesting the need for multifaceted approaches.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Artrite Reumatoide
/
Antirreumáticos
/
Fragilidade
Limite:
Humans
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article